This report contains market size and forecasts of Vaccine Contract Manufacturing in Global, including the following market information:
Global Vaccine Contract Manufacturing Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Vaccine Contract Manufacturing market was valued at 1781.6 million in 2020 and is projected to reach US$ 2171.5 million by 2027, at a CAGR of 5.1% during the forecast period.
Publisher has surveyed the Vaccine Contract Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccine Contract Manufacturing Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Vaccine Contract Manufacturing Market Segment Percentages, By Type, 2020 (%)
Fill-Finish
Bulk Product
China Vaccine Contract Manufacturing Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Vaccine Contract Manufacturing Market Segment Percentages, By Application, 2020 (%)
Pharmaceutical Companies
Biotech Companies
Others
Global Vaccine Contract Manufacturing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Vaccine Contract Manufacturing Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Vaccine Contract Manufacturing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Vaccine Contract Manufacturing Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Diosynth
Emergent BioSolutions
Goodwin Biotechnology
Bavarian Nordic
Soligenix Inc
Catalent Biologics
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Vaccine Contract Manufacturing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccine Contract Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccine Contract Manufacturing Overall Market Size
2.1 Global Vaccine Contract Manufacturing Market Size: 2021 VS 2027
2.2 Global Vaccine Contract Manufacturing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Vaccine Contract Manufacturing Players in Global Market
3.2 Top Global Vaccine Contract Manufacturing Companies Ranked by Revenue
3.3 Global Vaccine Contract Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Vaccine Contract Manufacturing Companies in Global Market, by Revenue in 2020
3.5 Global Companies Vaccine Contract Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vaccine Contract Manufacturing Players in Global Market
3.6.1 List of Global Tier 1 Vaccine Contract Manufacturing Companies
3.6.2 List of Global Tier 2 and Tier 3 Vaccine Contract Manufacturing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Vaccine Contract Manufacturing Market Size Markets, 2021 & 2027
4.1.2 Fill-Finish
4.1.3 Bulk Product
4.2 By Type - Global Vaccine Contract Manufacturing Revenue & Forecasts
4.2.1 By Type - Global Vaccine Contract Manufacturing Revenue, 2016-2021
4.2.2 By Type - Global Vaccine Contract Manufacturing Revenue, 2022-2027
4.2.3 By Type - Global Vaccine Contract Manufacturing Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vaccine Contract Manufacturing Market Size, 2021 & 2027
5.1.2 Pharmaceutical Companies
5.1.3 Biotech Companies
5.1.4 Others
5.2 By Application - Global Vaccine Contract Manufacturing Revenue & Forecasts
5.2.1 By Application - Global Vaccine Contract Manufacturing Revenue, 2016-2021
5.2.2 By Application - Global Vaccine Contract Manufacturing Revenue, 2022-2027
5.2.3 By Application - Global Vaccine Contract Manufacturing Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Vaccine Contract Manufacturing Market Size, 2021 & 2027
6.2 By Region - Global Vaccine Contract Manufacturing Revenue & Forecasts
6.2.1 By Region - Global Vaccine Contract Manufacturing Revenue, 2016-2021
6.2.2 By Region - Global Vaccine Contract Manufacturing Revenue, 2022-2027
6.2.3 By Region - Global Vaccine Contract Manufacturing Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Vaccine Contract Manufacturing Revenue, 2016-2027
6.3.2 US Vaccine Contract Manufacturing Market Size, 2016-2027
6.3.3 Canada Vaccine Contract Manufacturing Market Size, 2016-2027
6.3.4 Mexico Vaccine Contract Manufacturing Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Vaccine Contract Manufacturing Revenue, 2016-2027
6.4.2 Germany Vaccine Contract Manufacturing Market Size, 2016-2027
6.4.3 France Vaccine Contract Manufacturing Market Size, 2016-2027
6.4.4 U.K. Vaccine Contract Manufacturing Market Size, 2016-2027
6.4.5 Italy Vaccine Contract Manufacturing Market Size, 2016-2027
6.4.6 Russia Vaccine Contract Manufacturing Market Size, 2016-2027
6.4.7 Nordic Countries Vaccine Contract Manufacturing Market Size, 2016-2027
6.4.8 Benelux Vaccine Contract Manufacturing Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Vaccine Contract Manufacturing Revenue, 2016-2027
6.5.2 China Vaccine Contract Manufacturing Market Size, 2016-2027
6.5.3 Japan Vaccine Contract Manufacturing Market Size, 2016-2027
6.5.4 South Korea Vaccine Contract Manufacturing Market Size, 2016-2027
6.5.5 Southeast Asia Vaccine Contract Manufacturing Market Size, 2016-2027
6.5.6 India Vaccine Contract Manufacturing Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Vaccine Contract Manufacturing Revenue, 2016-2027
6.6.2 Brazil Vaccine Contract Manufacturing Market Size, 2016-2027
6.6.3 Argentina Vaccine Contract Manufacturing Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Vaccine Contract Manufacturing Revenue, 2016-2027
6.7.2 Turkey Vaccine Contract Manufacturing Market Size, 2016-2027
6.7.3 Israel Vaccine Contract Manufacturing Market Size, 2016-2027
6.7.4 Saudi Arabia Vaccine Contract Manufacturing Market Size, 2016-2027
6.7.5 UAE Vaccine Contract Manufacturing Market Size, 2016-2027
7 Players Profiles
7.1 Diosynth
7.1.1 Diosynth Corporate Summary
7.1.2 Diosynth Business Overview
7.1.3 Diosynth Vaccine Contract Manufacturing Major Product Offerings
7.1.4 Diosynth Vaccine Contract Manufacturing Revenue in Global (2016-2021)
7.1.5 Diosynth Key News
7.2 Emergent BioSolutions
7.2.1 Emergent BioSolutions Corporate Summary
7.2.2 Emergent BioSolutions Business Overview
7.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Major Product Offerings
7.2.4 Emergent BioSolutions Vaccine Contract Manufacturing Revenue in Global (2016-2021)
7.2.5 Emergent BioSolutions Key News
7.3 Goodwin Biotechnology
7.3.1 Goodwin Biotechnology Corporate Summary
7.3.2 Goodwin Biotechnology Business Overview
7.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Major Product Offerings
7.3.4 Goodwin Biotechnology Vaccine Contract Manufacturing Revenue in Global (2016-2021)
7.3.5 Goodwin Biotechnology Key News
7.4 Bavarian Nordic
7.4.1 Bavarian Nordic Corporate Summary
7.4.2 Bavarian Nordic Business Overview
7.4.3 Bavarian Nordic Vaccine Contract Manufacturing Major Product Offerings
7.4.4 Bavarian Nordic Vaccine Contract Manufacturing Revenue in Global (2016-2021)
7.4.5 Bavarian Nordic Key News
7.5 Soligenix Inc
7.5.1 Soligenix Inc Corporate Summary
7.5.2 Soligenix Inc Business Overview
7.5.3 Soligenix Inc Vaccine Contract Manufacturing Major Product Offerings
7.5.4 Soligenix Inc Vaccine Contract Manufacturing Revenue in Global (2016-2021)
7.5.5 Soligenix Inc Key News
7.6 Catalent Biologics
7.6.1 Catalent Biologics Corporate Summary
7.6.2 Catalent Biologics Business Overview
7.6.3 Catalent Biologics Vaccine Contract Manufacturing Major Product Offerings
7.6.4 Catalent Biologics Vaccine Contract Manufacturing Revenue in Global (2016-2021)
7.6.5 Catalent Biologics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Vaccine Contract Manufacturing Market Opportunities & Trends in Global Market
Table 2. Vaccine Contract Manufacturing Market Drivers in Global Market
Table 3. Vaccine Contract Manufacturing Market Restraints in Global Market
Table 4. Key Players of Vaccine Contract Manufacturing in Global Market
Table 5. Top Vaccine Contract Manufacturing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Vaccine Contract Manufacturing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Vaccine Contract Manufacturing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Vaccine Contract Manufacturing Product Type
Table 9. List of Global Tier 1 Vaccine Contract Manufacturing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccine Contract Manufacturing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Vaccine Contract Manufacturing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Vaccine Contract Manufacturing Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Vaccine Contract Manufacturing Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Vaccine Contract Manufacturing Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Vaccine Contract Manufacturing Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Vaccine Contract Manufacturing Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Vaccine Contract Manufacturing Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Vaccine Contract Manufacturing Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Vaccine Contract Manufacturing Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Vaccine Contract Manufacturing Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Vaccine Contract Manufacturing Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Vaccine Contract Manufacturing Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Vaccine Contract Manufacturing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Vaccine Contract Manufacturing Revenue, (US$, Mn), 2022-2027
Table 30. Diosynth Corporate Summary
Table 31. Diosynth Vaccine Contract Manufacturing Product Offerings
Table 32. Diosynth Vaccine Contract Manufacturing Revenue (US$, Mn), (2016-2021)
Table 33. Emergent BioSolutions Corporate Summary
Table 34. Emergent BioSolutions Vaccine Contract Manufacturing Product Offerings
Table 35. Emergent BioSolutions Vaccine Contract Manufacturing Revenue (US$, Mn), (2016-2021)
Table 36. Goodwin Biotechnology Corporate Summary
Table 37. Goodwin Biotechnology Vaccine Contract Manufacturing Product Offerings
Table 38. Goodwin Biotechnology Vaccine Contract Manufacturing Revenue (US$, Mn), (2016-2021)
Table 39. Bavarian Nordic Corporate Summary
Table 40. Bavarian Nordic Vaccine Contract Manufacturing Product Offerings
Table 41. Bavarian Nordic Vaccine Contract Manufacturing Revenue (US$, Mn), (2016-2021)
Table 42. Soligenix Inc Corporate Summary
Table 43. Soligenix Inc Vaccine Contract Manufacturing Product Offerings
Table 44. Soligenix Inc Vaccine Contract Manufacturing Revenue (US$, Mn), (2016-2021)
Table 45. Catalent Biologics Corporate Summary
Table 46. Catalent Biologics Vaccine Contract Manufacturing Product Offerings
Table 47. Catalent Biologics Vaccine Contract Manufacturing Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Vaccine Contract Manufacturing Segment by Type
Figure 2. Vaccine Contract Manufacturing Segment by Application
Figure 3. Global Vaccine Contract Manufacturing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Vaccine Contract Manufacturing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Vaccine Contract Manufacturing Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vaccine Contract Manufacturing Revenue in 2020
Figure 8. By Type - Global Vaccine Contract Manufacturing Revenue Market Share, 2016-2027
Figure 9. By Application - Global Vaccine Contract Manufacturing Revenue Market Share, 2016-2027
Figure 10. By Region - Global Vaccine Contract Manufacturing Revenue Market Share, 2016-2027
Figure 11. By Country - North America Vaccine Contract Manufacturing Revenue Market Share, 2016-2027
Figure 12. US Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Vaccine Contract Manufacturing Revenue Market Share, 2016-2027
Figure 16. Germany Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 17. France Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Vaccine Contract Manufacturing Revenue Market Share, 2016-2027
Figure 24. China Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 28. India Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Vaccine Contract Manufacturing Revenue Market Share, 2016-2027
Figure 30. Brazil Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Vaccine Contract Manufacturing Revenue Market Share, 2016-2027
Figure 33. Turkey Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Vaccine Contract Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 37. Diosynth Vaccine Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Emergent BioSolutions Vaccine Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Goodwin Biotechnology Vaccine Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bavarian Nordic Vaccine Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Soligenix Inc Vaccine Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Catalent Biologics Vaccine Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Diosynth
Emergent BioSolutions
Goodwin Biotechnology
Bavarian Nordic
Soligenix Inc
Catalent Biologics